Skip to main content
SpringerLink
Log in

Statins and the prevention of stroke in diabetes

  • Invited Commentary
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Goldstein LD, Adams R, Beeker K, et al.: Primary prevention of ischemic stroke: a statement of healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2001, 103:163–182.

    PubMed  CAS  Google Scholar 

  2. Howard BV, Rodriguez BL, Bennett PH, et al.: Prevention Conference VI. Diabetes and Cardiovascular Disease: Writing Group I: epidemiology. Circulation 2002, 105:e132-e137.

    Article  PubMed  Google Scholar 

  3. American Heart Association. Heart Disease and Stroke Statistics-2003 Update. Dallas, TX: American Heart Association; 2003.

    Google Scholar 

  4. Haffner SM, Lehto S, Ronnemaa T, et al.: Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetes subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229–234.

    Article  PubMed  CAS  Google Scholar 

  5. Malmberg K, Yusuf S, Gerstein HC, et al.: Impact of diabetes on long term prognosis in patients with unstable angina and non Q wave myocardial infarction: results of the OASIS Registry. Circulation 2000, 102:1014–1019.

    PubMed  CAS  Google Scholar 

  6. Haffner SM, Agostino RD Jr, Saad MF, et al.: Carotid artery atherosclerosis in type 2 diabetic and non-diabetic subjects with and without symptomatic coronary artery disease (the Insulin Resistance Atherosclerosis Study). Am J Cardiol 2000, 85:1395–1400.

    Article  PubMed  CAS  Google Scholar 

  7. Ho JE, Paultre F, Mosca L: Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women. Stroke 2003, 34:3812–2816.

    Article  Google Scholar 

  8. Lebovitz HE, Banerji MA: Treatment of insulin resistance in diabetes mellitus. Eur J Pharmacol 2004, 490:135–146.

    Article  PubMed  CAS  Google Scholar 

  9. Kothari V, Stevens RJ, Adler AI, et al.: Risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study Risk Engine. UKPDS 60. Stroke 2002, 33:1776–1781.

    Article  PubMed  Google Scholar 

  10. Stevens RJ, Statton IM, Coleman RL, et al.: Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes. UKPDS 66. Diabetes Care 2004, 27:201–207.

    Article  PubMed  Google Scholar 

  11. Chambless LE, Heiss G, Shahar E, et al.: Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2004, 160:259–269.

    Article  PubMed  Google Scholar 

  12. Tight blood pressure control and risk of macrovascular and microvascular complication in type 2 diabetes. UKPDS 38. United Kingdom Prospective Diabetes Study Group [no authors listed]. BMJ 1998, 317:703–713.

  13. Khaw KT, Wareham N, Bingham S, et al.: Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European Prospective Investigation into Cancer in Norfolk. Ann Intern Med 2004, 141:413–420.

    PubMed  CAS  Google Scholar 

  14. ACCORD Trial Website: Action to control cardiovascular risk in diabetes trial website. Accessible at http://www.accordtrial.org. Accessed December 10, 2004.

  15. Cholesterol, diastolic blood pressure and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration [no authors listed]. Lancet 1995, 346:1647–1653.

  16. Law MR, Wald NJ, Rudnicka AR: Quantifying the effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta analysis. BMJ 2003, 326:1423–1430.

    Article  PubMed  CAS  Google Scholar 

  17. Colhoun H, Betteridge DJ, Durrington PN, et al.: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (CARDS). Lancet 2004, 364:685–696.

    Article  PubMed  CAS  Google Scholar 

  18. Collins R, Armitage J, Parish S, et al.: Effects of cholesterol lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease and other high risk conditions. Lancet 2004, 363:757–767.

    Article  PubMed  Google Scholar 

  19. Collins R, Armitage J, Parish S, et al.: MRC/BHF Heart Protection Study with cholesterol with simvastatin in 5963 people with diabetes: a randomized placebo-controlled trial. Lancet 2003, 361:2005–2016.

    Article  PubMed  Google Scholar 

  20. Nissen SE, Tuzcu EM, Schoenhagen P, et al.: Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004, 291:1071–1080.

    Article  PubMed  CAS  Google Scholar 

  21. Amarenco P, Labreuche J, Lavallee P, Touboul PJ: Statins in stroke prevention and carotid atherosclerosis. Systematic review and up-to-date meta-analysis. Stroke 2004, 35:2902–2909.

    Article  PubMed  CAS  Google Scholar 

  22. Davignon J: Beneficial cardiovascular pleiotropic effects of statins. Circulation 2004, 109(23 suppl 1):III39-III43.

    PubMed  Google Scholar 

  23. Grundy SM, Cleeman JI, Mertz CND, et al.: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004, 110:227–239.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, SUNY Health Science Center, 450 Lenox Road, Box 123, 11203, Brooklyn, NY, USA

    Mary Ann Banerji MD, FACP

Authors
  1. Mary Ann Banerji MD, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Banerji, M.A. Statins and the prevention of stroke in diabetes. Curr Diab Rep 5, 1–3 (2005). https://doi.org/10.1007/s11892-005-0058-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-005-0058-4

Keywords

Search

Navigation